「Pulse Biosciences」(纳斯达克代码:PLSE)于5月1日宣布其签署了一份股票购买协议，根据协议，公司将进行约6500万美元的融资。据悉，该笔融资将主要 ...

来源：医械一线，未经授权不得转载，且24小时后方可转载。 近期，Pulse Biosciences宣布了完成了其脉冲场消融系统首次人体可行性研究。总部位于 ...

Pulse Biosciences是一家医疗技术研发商，公司研发的纳米脉冲刺激（NPS）技术可以提供有效的局部肿瘤控制，并通过诱导免疫原性细胞死亡来启动具有 ...

全球投资者法律顾问ROSEN鼓励蒙受损失的Pulse Biosciences, Inc.投资者在PLSE证券集体诉讼的重要截止日期4月18日之前聘请律师 April 06, 2022 03:08 PM Eastern ...

Pulse Biosciences（PLSE.US）公司简介：Pulse Biosciences Inc .是一家新型生物医药公司，致力于利用其获得专利的纳米脉冲刺激技术进行健康创新，这是一种 ...

Pulse Biosciences undertakes no obligation to revise or update information in this release to reflect events or circumstances in the future, even if new information becomes available.

Pulse Biosciences is a novel bioelectric medicine company committed to health innovation that has the potential to improve the quality of life for patients. The Company’s proprietary CellFX® nsPFA™ ...

Pulse Biosciences: Bioscience That Doesn't Get Our Pulse Racing Jan. 22, 2020 8:00 AM ET Pulse Biosciences, Inc. (PLSE) Stock APYX , CUTRQ , SOLY , PLSE 12 Comments Marvl Research ...

Thank you for standing by. My name is Malia, and I will be your conference operator today. At this time, I would like to welcome everyone to the Pulse Biosciences’ fourth-quarter 2024 earnings ...

Find the latest dividend history for Pulse Biosciences, Inc Common Stock (DE) (PLSE) at Nasdaq.com.

Pulse Biosciences, Inc., a novel bioelectric medicine company progressing Nano-Pulse Stimulation TM technology, announced today that on December 31, 2020, it delivered a notice of redemption to ...

Pulse Biosciences, Inc. (NASDAQ:PLSE) Q3 2023 Earnings Conference Call November 13, 2023 12:00 PM ETCompany Participants. Philip Taylor - IR Kevin Danahy - President and CEO Darrin Uecker - CTO ...